各行业的融资风险均呈现出多样化的表现形式,本文在对融资风险进行分类的基础上,运用功效系数法对生物制药板块的26个样本公司的融资风险进行了分析和比较,通过比较分析发现:11%的医药上市公司的融资风险处于极高状况,27.3%的融资风险处于较高状态,42.5%的处于一般水平,19.2%的处于较低状况,而没有融资风险良好的情况。 Financing risks of all industries show diversified manifestations. Based on the classification of financing risks, this paper analyzes and compares the financing risks of 26 sample companies in the bio-pharmaceutical sector by using the efficiency coefficient method. By comparative analysis Found that: 11% of listed companies in the pharmaceutical financing risk in the extremely high condition, 27.3% of the financing risk in a higher state, 42.5% in the general level, 19.2% at a lower condition, and no financing risk is good.